Abstract
Implantable cardioverter defibrillators (ICDs) are strongly recommended for primary prevention in patients with symptomatic heart failure and an ejection fraction less than 35% if meaningful survival greater than one year is expected. However, currently many people die within one year of ICD implantation. Current prediction models for death following primary prevention ICD placement have only modest discrimination.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
